# BioNexus Gene Lab Corp: filings

BGLC · Nasdaq · CIK 1737523 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bglc.md) · [Financials](/companies/bglc/financials.md) · [Filings](/companies/bglc/filings.md) · [Insiders](/companies/bglc/insiders.md)

## Reports and events: 101 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 48, 10-Q 23, 3 16, 10-K 7, 10-Q/A 5, 4 5, NT 10-K 5, NT 10-Q 5, S-1/A 5, UPLOAD 4, 10-K/A 3, 8-K/A 3, CORRESP 3, DEF 14A 3, DEF 14C 3, PRE 14A 3, EFFECT 2, PRE 14C 2, S-1 2, 424B4 1, 8-A12B 1, CERT 1, DEFR14A 1, DEFR14C 1, S-3 1, SC 13D 1, SC 13G 1, SCHEDULE 13D 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-07 | 13:00 ET | [8-K](/filings/0001477932-26-006075.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-26-006075 |
| 2026-08-14 | 21:29 ET | [SCHEDULE 13D](/filings/0001520138-26-000354.md) | Ownership report, active investor | 0001520138-26-000354 |
| 2026-08-14 | 21:00 ET | [10-Q](/filings/0001477932-26-005093.md) | Quarterly report, period 2026-06-30 | 0001477932-26-005093 |
| 2026-07-28 | 18:30 ET | [8-K](/filings/0001477932-26-004556.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-26-004556 |
| 2026-06-05 | 13:00 ET | [8-K](/filings/0001477932-26-003658.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-26-003658 |
| 2026-05-15 | 21:15 ET | [10-Q](/filings/0001477932-26-003242.md) | Quarterly report, period 2026-03-31 | 0001477932-26-003242 |
| 2026-04-14 | 21:20 ET | [10-K](/filings/0001477932-26-002218.md) | Annual report, period 2025-12-31 | 0001477932-26-002218 |
| 2026-03-17 | 18:30 ET | [8-K](/filings/0001477932-26-001379.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-26-001379 |
| 2026-02-23 | 13:35 ET | [8-K](/filings/0001477932-26-000964.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-26-000964 |
| 2026-02-03 | 21:10 ET | [8-K](/filings/0001477932-26-000610.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-26-000610 |
| 2025-12-30 | 18:30 ET | [8-K](/filings/0001477932-25-009240.md) | 5.07 Shareholder vote results | 0001477932-25-009240 |
| 2025-12-23 | 22:20 ET | [8-K](/filings/0001477932-25-009186.md) | 8.01 Other events | 0001477932-25-009186 |
| 2025-12-03 | 22:15 ET | [DEF 14A](/filings/0001477932-25-008757.md) | Proxy statement, period 2025-12-24 | 0001477932-25-008757 |
| 2025-12-02 | 13:00 ET | [8-K](/filings/0001477932-25-008724.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-25-008724 |
| 2025-11-14 | 22:21 ET | [10-Q](/filings/0001477932-25-008343.md) | Quarterly report, period 2025-09-30 | 0001477932-25-008343 |
| 2025-11-13 | 13:00 ET | [8-K](/filings/0001477932-25-008137.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-25-008137 |
| 2025-11-12 | 13:32 ET | [8-K](/filings/0001477932-25-008044.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-25-008044 |
| 2025-10-23 | 12:00 ET | [8-K](/filings/0001477932-25-007708.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-25-007708 |
| 2025-08-18 | 20:48 ET | [10-Q](/filings/0001477932-25-006023.md) | Quarterly report, period 2025-06-30 | 0001477932-25-006023 |
| 2025-07-30 | 14:30 ET | [8-K](/filings/0001477932-25-005322.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-25-005322 |
| 2025-06-23 | 19:00 ET | [8-K](/filings/0001477932-25-004754.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001477932-25-004754 |
| 2025-05-15 | 20:30 ET | [10-Q](/filings/0001477932-25-003821.md) | Quarterly report, period 2025-03-31 | 0001477932-25-003821 |
| 2025-04-30 | 15:16 ET | [8-K](/filings/0001477932-25-003114.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-25-003114 |
| 2025-04-29 | 19:22 ET | [10-K/A](/filings/0001477932-25-003062.md) | Annual report, amended, period 2024-12-31 | 0001477932-25-003062 |
| 2025-04-15 | 15:00 ET | [10-K](/filings/0001477932-25-002725.md) | Annual report, period 2024-12-31 | 0001477932-25-002725 |
| 2025-04-10 | 15:50 ET | [8-K](/filings/0001477932-25-002574.md) | 3.03 Change to security holders’ rights | 0001477932-25-002574 |
| 2025-04-03 | 13:31 ET | [8-K](/filings/0001477932-25-002406.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001477932-25-002406 |
| 2025-03-25 | 17:15 ET | [8-K](/filings/0001477932-25-001958.md) | 5.07 Shareholder vote results | 0001477932-25-001958 |
| 2025-03-07 | 16:00 ET | [8-K](/filings/0001477932-25-001531.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-25-001531 |
| 2025-03-05 | 16:02 ET | [8-K](/filings/0001477932-25-001484.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-25-001484 |
| 2025-02-27 | 22:20 ET | [DEF 14A](/filings/0001477932-25-001335.md) | Proxy statement, period 2025-03-19 | 0001477932-25-001335 |
| 2025-02-14 | 22:20 ET | [8-K](/filings/0001477932-25-001063.md) | 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001477932-25-001063 |
| 2025-01-02 | 15:30 ET | [8-K](/filings/0001477932-25-000006.md) | 3.01 Delisting notice | 0001477932-25-000006 |
| 2024-11-15 | 22:00 ET | [10-Q](/filings/0001477932-24-007332.md) | Quarterly report, period 2024-09-30 | 0001477932-24-007332 |
| 2024-11-08 | 22:25 ET | [8-K](/filings/0001477932-24-006996.md) | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors | 0001477932-24-006996 |
| 2024-10-15 | 21:20 ET | [8-K](/filings/0001477932-24-006440.md) | 5.02 Departure or appointment of officers or directors | 0001477932-24-006440 |
| 2024-10-10 | 21:29 ET | [8-K](/filings/0001477932-24-006352.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001477932-24-006352 |
| 2024-09-25 | 15:30 ET | [8-K](/filings/0001477932-24-005924.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-24-005924 |
| 2024-09-18 | 18:13 ET | [8-K](/filings/0001477932-24-005817.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-24-005817 |
| 2024-09-16 | 21:20 ET | [DEF 14A](/filings/0001477932-24-005760.md) | Proxy statement, period 2024-10-04 | 0001477932-24-005760 |
| 2024-09-12 | 19:01 ET | [8-K](/filings/0001477932-24-005680.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-24-005680 |
| 2024-09-05 | 17:00 ET | [8-K](/filings/0001477932-24-005537.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001477932-24-005537 |
| 2024-08-28 | 14:02 ET | [8-K](/filings/0001477932-24-005339.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-24-005339 |
| 2024-08-26 | 16:05 ET | [8-K](/filings/0001477932-24-005269.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-24-005269 |
| 2024-08-14 | 18:15 ET | [10-Q](/filings/0001477932-24-004792.md) | Quarterly report, period 2024-06-30 | 0001477932-24-004792 |
| 2024-07-05 | 21:15 ET | [8-K/A](/filings/0001477932-24-004096.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001477932-24-004096 |
| 2024-05-31 | 19:47 ET | [10-K/A](/filings/0001477932-24-003422.md) | Annual report, amended, period 2023-12-31 | 0001477932-24-003422 |
| 2024-05-31 | 19:46 ET | [10-Q/A](/filings/0001477932-24-003421.md) | Quarterly report, amended, period 2023-09-30 | 0001477932-24-003421 |
| 2024-05-31 | 19:46 ET | [10-Q/A](/filings/0001477932-24-003420.md) | Quarterly report, amended, period 2023-06-30 | 0001477932-24-003420 |
| 2024-05-31 | 19:45 ET | [10-Q/A](/filings/0001477932-24-003419.md) | Quarterly report, amended, period 2023-03-31 | 0001477932-24-003419 |

Page 1 of 3. [Older](/companies/bglc/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.